New Treatments And Research On Genital Herpes

If you’ve just received a genital herpes diagnosis, you may be wondering what treatment options are available to you. Unfortunately, no cure for the herpes simplex virus currently exists. Scientists have been performing advanced research on genital herpes in the attempts to discover a preventative cure. The latest technologies include the testing of vaccinations, microbicides and new drugs.

An HSV-2 Vaccination in the Works?

In 2000, an experimental vaccination underwent rigorous testing. Two prominent clinical trials discovered that the vaccine in question was largely successful in preventing genital herpes (HSV-2) when compared with the results of the placebo.
The vaccine displayed several important limitations, one of which being that it was only effective in women who hadn’t previously been exposed to HSV-1 (oral herpes). These limitations in the vaccination have made it unfit for mass use.
Scientists are continuing to conduct experiments to create a vaccine, while battling the public’s skepticism of the possibility.

Killing Microbes to Kill the Disease

Microbicides combat infection by killing microbes, which are small organisms like viruses and bacteria. Scientists are studying the effectiveness of using microbicides in killing the herpes virus and other potential sexually transmitted diseases (STDs) before they can enter the body.
One promising product is called BufferGel. This microbial spermicide is applied to the vagina before intercourse so that when skin-to-skin contact is made, the virus will be killed on contact. It’s believed to help stop the spreading of genital herpes and other STDs, but the rate of effectiveness in unknown.

New Drugs on the Horizon

The current drugs available for treating the herpes simplex virus include antiviral medications that are meant to suppress and relieve symptoms.
Scientists have been working with new drugs that may keep the virus from replicating itself. Viruses have the ability to replicate DNA exactly, and it’s hoped that these drugs will destroy that ability.
New drugs and treatments are always in the works, but the process of approving a new drug often takes an extensive amount of time. It must go through many clinical trials to prove its effectiveness and safety to the public. Hopefully, as the trial stages of these new drugs advance, the world will see new means of preventing the HSV-2 virus and reducing the long-term effects of genital herpes in those who are already affected.